Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

BODE B., MERTENS A., Cho Y., CHRISTIANSEN E., Hertz C. L. , Wallenstein S. O. R. , ...More

The Lancet Diabetes and Endocrinology, vol.7, no.7, pp.528-539, 2019 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 7
  • Publication Date: 2019
  • Doi Number: 10.1016/s2213-8587(19)30194-9
  • Journal Name: The Lancet Diabetes and Endocrinology
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.528-539